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Abstract. 
 
Amphiphysin (amphiphysin I), a dominant 
autoantigen in paraneoplastic Stiff-man syndrome, is a 
neuronal protein highly concentrated in nerve termi-
nals, where it has a putative role in endocytosis. The 
yeast homologue of amphiphysin, Rvs167, has pleiotro-
pic functions, including a role in endocytosis and in ac-
tin dynamics, suggesting that amphiphysin may also be 
implicated in the function of the presynaptic actin cy-
toskeleton. We report here the characterization of a 
second mammalian amphiphysin gene, amphiphysin II 
(SH3P9; BIN1), which encodes products primarily ex-
pressed in skeletal muscle and brain, as differentially 
spliced isoforms. In skeletal muscle, amphiphysin II is 
concentrated around T tubules, while in brain it is con-
centrated in the cytomatrix beneath the plasmamem-
brane of axon initial segments and nodes of Ranvier. In 
both these locations, amphiphysin II is colocalized with 
splice variants of ankyrin3 (ankyrin
 
G
 
), a component of 
the actin cytomatrix. In the same regions, the presence 
of clathrin has been reported. These findings support 
the hypothesis that, even in mammalian cells, amphi-
physin/Rvs family members have a role both in endocy-
tosis and in actin function and suggest that distinct am-
phiphysin isoforms contribute to define distinct 
domains of the cortical cytoplasm. Since amphiphysin 
II (BIN1) was reported to interact with Myc, it may also 
be implicated in a signaling pathway linking the cortical 
cytoplasm to nuclear function.
 
A
 
mphiphysin
 
 I, a human autoantigen in Stiff-man syn-
drome associated with breast cancer (De Camilli
et al., 1993; Folli et al., 1993), is a neuronal protein
highly concentrated in the cortical cytomatrix of nerve ter-
minals where it has a putative role in synaptic vesicle en-
docytosis (Lichte et al., 1992; David et al., 1994, 1996; Shu-
pliakov et al., 1997). It comprises an NH
 
2
 
-terminal region,
which is predicted to form coiled coil structures, a COOH-
terminal SH3 domain, and a proline-rich linker region be-
tween these two domains that is poorly conserved evolu-
tionarily (David et al., 1994). Biochemical studies, comple-
mented by colocalization and coimmunoprecipitation
experiments, have strongly suggested that the two main
physiological ligands for the SH3 domain of amphiphysin I
are the GTPase dynamin I (David et al., 1996; Grabs et al.,
1997) and the inositol–5-phosphatase synaptojanin (McPher-
son et al., 1996). Dynamin I participates in synaptic vesicle
recycling via its critical role in the fission of clathrin-
coated vesicles from the nerve terminal plasmalemma
(Kosaka and Ikeda, 1983; Koenig and Ikeda, 1989; Shpet-
ner and Vallee, 1989; Takei et al., 1995), and synaptojanin
is thought to function in a closely related step (McPherson
et al., 1996). In addition, amphiphysin I interacts in vitro,
via a region distinct from its SH3 domain, with the ap-
pendage domain of the 
 
a
 
 subunit of the clathrin adaptor
AP2 (Wang et al., 1995; David et al., 1996). It has, there-
fore, been suggested that one of the functions of amphi-
physin I is to recruit dynamin I and synaptojanin at the
clathrin coat of synaptic vesicles (David et al., 1996).
Consistent with this hypothesis, disruption of amphiphysin
SH3 domain interactions in living nerve terminals pro-
duces a potent block of synaptic vesicle endocytosis at the
stage of deeply invaginated clathrin coated pits (Shuplia-
kov et al., 1997).
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Amphiphysin I shares substantial primary sequence sim-
ilarity and a similar domain structure, with the yeast pro-
tein Rvs167. Furthermore, the NH
 
2
 
-terminal portion of
both proteins is similar to the yeast protein Rvs161 (Bauer
et al., 1993; David et al., 1994; Sivadon et al., 1995). Mutations
in either 
 
RVS161
 
 or 
 
RVS167
 
 block receptor-mediated and
fluid phase endocytosis in yeast, strongly supporting a role
of the Amphiphysin/Rvs family in endocytic processes
(Munn et al., 1995). In addition, 
 
RVS161
 
 and 
 
RVS167
 
 mu-
tants also exhibit defects in the function of the actin cy-
toskeleton, in agreement with the general link between ac-
tin and endocytosis that has emerged from yeast studies
(Munn et al., 1995; Sivadon et al., 1995). A corresponding
link between amphiphysin I and the function of the actin
cytoskeleton has been suggested by studies in cultured
hippocampal neurons (Mundigl O., C. Ochoa, C. David,
A.K. Kabanov, and P. De Camilli. 
 
Mol. Biol. Cell (Suppl.).
 
7:84
 
a.
 
). Finally, 
 
rvs
 
 mutants impair the ability of yeast cells
to enter stationary phase upon exposure to nutrient star-
vation (reduced viability upon starvation) suggesting an
indirect role of the 
 
RVS
 
 genes in controlling cell prolifera-
tion (Crouzet et al., 1991; David et al., 1994).
Amphiphysin I is expressed at a high concentration in
brain and testis, at a lower concentration in neuroendo-
crine tissues (De Camilli et al., 1993; Folli et al., 1993;
Lichte et al., 1992), and at only much lower levels in most
other tissues (Butler, M.H., S. Floyd, and P. De Camilli,
unpublished results). We have characterized here the
product of a second amphiphysin gene, which we refer to
as amphiphysin II. Amphiphysin II is localized primarily in
specialized regions of the cortical cytoplasm of axons and
muscle cells. These observations add further evidence for
a general connection between proteins of the amphi-
physin/Rvs family and the function of the cortical cell cy-
toskeleton.
 
Materials and Methods
 
Antibodies
 
The following affinity purified rabbit polyclonal antibodies were gener-
ated in our laboratory. CD5 antibodies specific for amphiphysin I (raised
against a GST-fusion protein comprising the full length amphiphysin I pro-
tein [David et al., 1994]); CD7 and CD8 antibodies specific for amphi-
physin II (raised against a GST-fusion protein comprising the last 68
amino acids of amphiphysin II; in this region, the amino acid identity be-
tween amphiphysin I and II is 55%); CD9 antibodies directed against both
amphiphysin I and II (raised against a synthetic peptide corresponding to
amino acids 26 to 40 of amphiphysin I, which is 100% conserved in amphi-
physin II). A mouse polyclonal serum specific for amphiphysin I was
raised against the polyhistidine-tagged full length amphiphysin I protein
(David et al., 1996). Rabbit polyclonal antibodies directed against synap-
tojanin were previously described (McPherson et al., 1996). DG1 antibod-
ies specific for dynamin I were generated against a dynamin I GST-fusion
protein lacking the proline-rich domain. Antibodies directed against
desmin, MAP2, and myelin basic protein (MBP) were purchased from Im-
munon (Pittsburgh, PA), Boehringer Mannheim Corp. (Indianapolis, IN),
and Sternberger Monoclonals (Baltimore, MD), respectively. Polyclonal
anti-ankyrin3 antibodies and anti-glut4 antibodies were kind gifts of J.
Morrow (Yale University, New Haven, CT; Devarajan et al., 1996) and D.
James (University of Queensland, Australia), respectively. A monoclonal
anti-clathrin antibody (X22) was a kind gift of F. Brodsky (University of
California, San Francisco, CA; Brodsky, 1985). A mouse monoclonal anti-
body (GAD6) against glutamic acid decarboxylase (GAD) was a kind gift
of D. Gottlieb (Washington University, St. Louis, MO; Chang and Gott-
lieb, 1988).
 
DNA Cloning
 
By searching the database for amphiphysin I homologues, a sequence of
289 bp was identified from a human muscle library with 76% identity to
the COOH-terminal region of human amphiphysin I. (These sequence
data are available from Genbank/EMBL/DDBJ under accession Z24784.)
A probe corresponding to the first 251 bp of this sequence was amplified
by PCR (forward primer 5
 
9
 
-cccaagcacgactacacggc-3
 
9
 
; reverse primer 5
 
9
 
-
ggaggaggtgttcttcacacgc-3
 
9
 
) from a human skeletal muscle cDNA library
constructed in 
 
l
 
ZAPII phage (Stratagene, La Jolla, CA). The probe was
then radioactively labeled by primer-direct labeling (Bogue et al., 1994)
and used to screen 2 
 
3
 
 10
 
6
 
 plaques of the same library. The two longest
clones isolated by the screen (clones 17-42 and 12-1A) were partially char-
acterized by restriction mapping and found to overlap extensively. Both
clones were fully sequenced, and clone 17-42 was found to encode a nearly
full length protein, missing only three amino acids at its COOH-terminal
end. Subsequent searches of the database revealed additional expressed
sequence tag (EST) sequences from a human infant brain library that
were identical to portions of our clone 17-42. Clones 24660, 30686, and
27466 (Genbank/EMBL/DDBJ T80281, R18250 and R12992, respectively)
were obtained through the IMAGE Consortium (Research Genetics Inc.,
Huntsville, AL) and fully sequenced. A human brain cDNA library con-
structed in 
 
l
 
gt11 (Clontech, Palo Alto, CA) was then screened with a 220-
bp probe amplified by PCR (forward primer 5
 
9
 
-cttggggagggtggccccg-3
 
9
 
;
reverse primer 5
 
9
 
-agcaagctcaaccagaacc-3
 
9
 
) and labeled by primer-direct
labeling. 26 positive plaques out of 1 
 
3
 
 10
 
6
 
 were identified, and the two
longest clones (clone 11 and clone 19) were fully sequenced. These clones
were identical to the IMAGE cDNA clones mentioned above, except for
some additional alternative splicings (see Fig. 1 
 
B
 
). Since none of the
clones isolated encoded an entire reading frame, the full length clones
were assembled as follows starting from the two longest clones. Clone 17/12
(see Fig. 1 
 
C
 
) was assembled from clone 17-42 by replacing its COOH ter-
minus with that of clone 12-1A using the SapI restriction site. Clone 17/19
(see Fig. 1 
 
C
 
) was assembled from clone 19 (Genbank/EMBL/DDBJ
U87558) by replacing its NH
 
2
 
-terminal region with that of clone 17-42 at
the unique restriction site BsaAI. Nucleotide sequences were analyzed by
Blast and Fasta and aligned by Bestfit and Pileup (Genetics Computer
Group, Madison, WI). Chromatograms from sequencing analysis were as-
sembled by Seqman (DNASTAR, Inc., Madison, WI). Coiled coil struc-
ture identification was performed using Coils 2.2 (Lupas, 1996).
 
Northern Blot Analysis
 
Northern blot analysis of amphiphysin II expression was performed on a
human multiple tissue RNA filter (Clontech) containing 2 
 
m
 
g of Poly A
 
1
 
RNA on each lane. The full length amphiphysin II cDNA (clone 17/12)
and an oligonucleotide of 120 bp corresponding to amino acid 351–390 of
the contiguous sequence shown in Fig. 1 
 
A
 
, were labeled by random prim-
ing (Boehringer Mannheim Corp.; 2 
 
3
 
 10
 
6
 
 cpm/ml) and hybridized at 42
 
8
 
C
in 50% formamide, 6
 
3
 
 SSC, 0.1% SDS, 2
 
3
 
 Denhardt’s, 100 
 
m
 
g/ml salmon
sperm DNA. An actin probe was used as a control to assess gel loading.
Filters were washed twice for 20 min at high stringent conditions in 0.2
 
3
 
SSC, 0.1% SDS at 50
 
8
 
C.
 
Cell Transfection
 
COS-7 cells were transiently transfected with cDNAs corresponding to ei-
ther clone 17/12 or clone 17/19 (see Fig. 1 
 
C
 
). The two cDNAs were sub-
cloned in pcDNA3 (Invitrogen, San Diego, CA) and then purified with a
Maxiprep kit (Qiagen, Chatsworth, CA). COS-7 cells (American Type
Culture Collection, Rockville, MD) were transfected with lipofectamine
(GIBCO BRL, Gaithersburg, MD), according to standard procedures
(Chen and Okayama, 1987). Triton X-100 extracts of transfected cells and
untransfected COS-7 cells were harvested after 24 h and analyzed by SDS-
PAGE and Western blotting.
 
Immunocytochemistry
 
Light microscopy. 
 
Rat brains were fixed and frozen sectioned as described
(De Camilli et al., 1983). Small fragments of rat soleus skeletal muscle
were incubated in relaxing media (100 mM Hepes, 100 mM potassium pro-
pionate, 3 mM MgCl, 5 mM EGTA, 15 mM phosphocreatine, 2 mM NaATP;
Kaufman et al., 1990) at room temperature for 10 min. Muscles were then
stretched, fixed in 4% paraformaldehyde/0.1 M phosphate buffer, pH 7.4,
and semithin sectioned (0.5 mm) on an ultramicrotome (Ultracut FCS;
Reichert, Vienna, Austria). Rat muscle and brain sections were stained 
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for indirect immunofluorescence according to De Camilli et al. (1983).
Pictures were recorded on black and white films (T-MAX 100; Kodak,
Rochester, NY) with a microscope (Axiophot; Zeiss Inc., Thornwood,
NY) equipped for epifluorescence microscopy.
Figure 1. (A) Human am-
phiphysin II contiguous se-
quence obtained from a
Pileup analysis of the human
clones shown in B. Alterna-
tively spliced regions are de-
picted by shaded amino acid
residues. (B) Schematic rep-
resentation of the human
amphiphysin II clones ana-
lyzed in this study and of the
mouse homologue of am-
phiphysin II previously re-
ported (Sparks et al., 1996).
The calibration bar (top)
indicates number of amino
acid residues. Alternatively
spliced regions are indicated
by roman numerals (I–IV).
(C) Schematic representa-
tion of full length amphi-
physin II clones assembled
from clones 17-42 and 12-1A
and from clones 19 and 17-
42, respectively. Clone 17/12
is identical to the recently re-
ported BIN1 clone with the
exception of a K®E differ-
ence at position 434 of BIN1
and the corresponding posi-
tion 591 of the contiguous se-
quence shown in Fig. 1 A
(Sakamuro et al., 1996). (D)
Domain diagram of human
amphiphysins I and II show-
ing the homology between
the two genes. The bound-
aries of the A–D domains are
delineated by amino acid
numbers. A–D domains were
previously defined as follows
based on comparisons among
human and chicken amphi-
physin I and yeast Rvs pro-
teins (David et al., 1994). The
A, B, and D domains are the
regions most highly con-
served between chicken and
human amphiphysin, while
the C domain is poorly con-
served. The A domain,
within the A and B region, is
defined by the yeast proteins
Rvs161, which comprises
this domain only. The per-
cent similarity and identity
(in parenthesis) for each do-
main is given. The shaded ar-
eas in the amphiphysin II
gene represent the alterna-
tively spliced regions out-
lined in Fig. 1 B.
 
Electron microscopy. 
 
Small pieces of rat soleus skeletal muscle were
rapidly excised and fixed by immersion in 4% paraformaldehyde in 0.12 M
sodium phosphate buffer, pH 7.4. The samples were then infiltrated with
polyvinylpyrrolidone/sucrose for 2 h. Ultrathin frozen sections were cut 
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onto an ultramicrotome (Reichert) with FCS attachment and immediately
processed for immunogold labeling (10-nm gold) as previously described
(Keller et al., 1984; Tokuyasu et al., 1989).
 
Miscellaneous Procedures
 
SDS-PAGE and Western blotting were performed essentially as de-
scribed by Laemmli (1970) and Towbin et al. (1979), respectively. Immu-
noreactive bands were detected by either alkaline phosphatase conjugated
secondary antibodies (Bio Rad, Hercules, CA) or 
 
125
 
I-protein A (10
 
5
 
 cpm/
ml; Dupont/NEN, Boston, MA).
 
Results
 
Cloning of Amphiphysin II
 
Human adult skeletal muscle and brain cDNA libraries
were screened with probes corresponding to human par-
tial cDNA sequences present in the database with signifi-
cant homology to human amphiphysin I. Four clones iden-
tified by this screening (muscle clones 17-42 and 12-1A
and brain clones 11 and 19) and three human infant brain
clones (clones 24660, 27466, and 30686) obtained from the
IMAGE Consortium were fully sequenced.
A comparative analysis of all these clones suggests that
they are derived by alternative splicing from a single gene.
The products of this gene will be collectively referred to as
amphiphysin II, because of their strong sequence similar-
ity to amphiphysin I. The contiguous amino acid sequence
derived from the analysis of the individual human clones is
shown in Fig. 1 
 
A.
 
 Fig. 1 
 
B 
 
is a schematic alignment of the
human clones with a mouse sequence (SH3P9) that repre-
sents the murine homologue of amphiphysin II and which
was obtained during a screen for SH3 domain-containing
proteins (Sparks et al., 1996). The partial clones depicted
in Fig. 1 
 
B
 
 were used to assemble the full length clones 17/12
and 17/19, as shown in Fig. 1 
 
C
 
 (see Materials and Meth-
ods). These full length clones correspond to two alternative
splicing variants of amphiphysin II. Clone 17/12 is identical
to BIN1 (with the exception of a single amino acid; see Fig.
1 
 
C
 
, 
 
legend
 
), a protein recently identified in a two hybrid
screen for MYC-interacting proteins (Sakamuro et al.,
1996).
The percentages of similarity and identity between the
contiguous sequence of human amphiphysin II (as defined
by Fig. 1 
 
A
 
) and human amphiphysin I (David et al., 1994)
are 71 and 55%, respectively. Fig. 1 
 
D
 
 shows a schematic
alignment of the two sequences, as well as the boundaries
of the A–D domains as defined previously on the basis of
blocks of similarity between the Rvs yeast proteins and
human and chicken amphiphysins (David et al., 1994; Fig.
1, 
 
legend
 
).
Note that alternatively spliced fragments I and II (Fig.
1 
 
B
 
) of amphiphysin II coincide with gaps in the amphi-
Figure 2. Northern blot anal-
ysis of human tissues demon-
strating patterns of expres-
sion of amphiphysin II
mRNAs. Two identical blots
containing Poly(A1) RNA
from a variety of tissues were
probed with clone 17/12 (A)
and a probe corresponding to
alternatively spliced seg-
ment III (B). Note the differ-
ent labeling patterns pro-
duced by the two probes.
Amphiphysin II is expressed
primarily in skeletal muscle
and brain. Numbers at left in-
dicate molecular weights (kb). 
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physin I sequence, raising the possibility that even the am-
phiphysin I gene may undergo a similar alternative splic-
ing in this region.
 
Amphiphysin II Is Primarily Expressed in Brain
and Muscle
 
Northern blot analysis of different tissues with the full
length amphiphysin II cDNA (clone 17/12) revealed that
skeletal muscle is, by far, the major site of expression of
this gene (Fig. 2 
 
A
 
). A major band centered at 2.2 kb was
present in this tissue. The same band was present at much
lower levels in brain and at an even lower concentration in
several other tissues (Fig. 2 
 
A
 
). Several minor transcripts
were also visible, including a band of 3 kb in brain. Since
the putative alternatively spliced sequence III was only de-
tected in brain clones (Fig. 1 
 
B
 
), we probed a blot identical
to that of Fig. 2 
 
A
 
 with constructs generated by PCR and
corresponding either to this entire sequence (Fig. 1 
 
A
 
,
amino acids 350–472) or to its 5
 
9
 
 portion (Fig. 1 
 
A
 
, amino
acids 350–390). Both probes produced an identical pattern
(Fig. 2 
 
B
 
 and data not shown) and labeled bands with sim-
ilar mobility as those labeled by the full length probe
(clone 17/12) but with different relative intensities. The
most striking difference is a strong labeling of the 3-kb
band in brain and the weaker labeling of transcripts mi-
grating at the 2.2-kb region. These observations confirm
the preferential inclusion of splice segment III in brain
amphiphysin II. No cross-reactivity with amphiphysin I
mRNA (major transcript at 4.5 kb [David et al., 1994]) was
observed in the high stringency conditions at which the
Northern blot analysis was performed.
To determine the electrophoretic mobility and the tissue
distribution of amphiphysin II, two rabbit antibodies (CD7
and CD8) were raised against the COOH-terminal 68
amino acids of amphiphysin II and tested by Western blot-
ting against a variety of tissues (Fig. 3 
 
A
 
 and data not
shown). These antibodies specifically recognized very
strongly a cluster of bands around 85 kD in brain and
around 60 kD in skeletal muscle (Fig. 3 
 
A
 
) and did not re-
act with amphiphysin I. Bands of similar molecular weight
were seen in other tissues (primarily lung) only after very
prolonged autoradiographic exposures (not shown). In
these long exposures, the 85-kD band was also detectable
in skeletal muscle in agreement with the Northern blot
data of Fig. 2 
 
B.
 
 In addition, a prominent band of 35 kD
was visible in skeletal muscle (Fig. 3 
 
A
 
). As seen by a com-
parison of Figs. 2 and 3 
 
A
 
, there is a discrepancy between
overall levels of amphiphysin II proteins and amphiphysin
II mRNAs detected in muscle and brain. This discrepancy
 
Figure 3.
 
(
 
A
 
) Tissue distribution of amphiphysin II as demon-
strated by Western blotting. Amphiphysin II is expressed prima-
rily in brain and skeletal muscle. Equal protein amounts of post
nuclear supernatants prepared from rat tissues were loaded in
each lane and probed with the CD8 polyclonal rabbit serum spe-
cific for amphiphysin II. Bound antibodies were detected by 
 
125
 
I-
protein A. (
 
B
 
) Comparison of amphiphysin I and amphiphysin II
expression in rat brain, skeletal muscle, and lung. Extracts of the
three tissues were probed with an antibody specific for amphi-
physin I (CD5), for amphiphysin II (CD8), and with an antibody
that recognizes both amphiphysin I and II (CD9). Bound anti-
bodies were detected by 
 
125
 
I-protein A. The low molecular weight
bands labeled by the CD8 antibody are not visible in the brain
and lung lanes of Fig. 3 
 
A
 
 because they had migrated at the gel
front. Numbers at left indicate molecular weights (kD). 
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may be partially explained by a less efficient extractability
of amphiphysin II from skeletal muscle. Alternatively, it
may be due to the occurrence of major differences in am-
phiphysin II mRNA translation efficiency and/or in pro-
tein turnover in the two tissues.
To corroborate the identification of the brain and mus-
cle bands as amphiphysin II, a distinct antiserum (CD9)
was raised against a 15-mer peptide corresponding to
amino acids 26–40 of amphiphysin I, which is identical to
the corresponding region of amphiphysin II. This antibody
recognized both the 128-kD brain amphiphysin I band (as
the CD5 antibody does) and the bands immunoreactive
with the amphiphysin II-specific antibody CD8 (Fig. 3 
 
B
 
).
The CD9 antibody also recognized a few other bands in
brain, suggesting the existence of additional amphiphysin
isoforms. The CD7/CD8-immunoreactive 35-kD protein
band of skeletal muscle was not recognized by the CD9
antibody and may therefore represent a variant of amphi-
physin II that does not include its NH
 
2
 
-terminal domain.
(Henceforth, we will refer to the brain 85- and muscle 60-
kD bands as amphiphysin IIa and IIb, respectively.)
Both amphiphysin IIa and IIb were recognized by anti-
bodies directed against either NH
 
2
 
-terminal (CD 9) or
COOH-terminal (CD7 and CD8) epitopes. Their different
mobility suggests therefore internal alternative splicing.
Most likely, this difference reflects the presence of splice
fragment III (127 amino acids) in amphiphysin IIa. This
Figure 4. Comparison of the
electrophoretic mobility of
amphiphysin II expressed in
COS-7 cells with the electro-
phoretic mobilities of muscle
and brain amphiphysin II.
Triton X-100 extracts of tis-
sues and COS-7 cells were
probed by Western blotting
with the amphiphysin II spe-
cific antibody, CD7. Lanes
are as follows: 1, control untransfected COS-7 cells; 2, rat brain;
3, COS-7 cells transfected with clone 17/19; 4, COS-7 cells trans-
fected with clone 17/12; 5, skeletal muscle. Immunoreactive
bands were detected by using alkaline phosphatase-conjugated
anti–rabbit IgG. Numbers at left indicate molecular weights
(kD).
 
Figure 5.
 
Comparison of the localization of amphiphysin I
(mouse polyclonal serum) and amphiphysin II (rabbit antibody
CD8) in rat brain. Double immunofluorescence micrographs. In
all fields, amphiphysin I immunoreactivity (
 
B
 
, 
 
D
 
, and 
 
F
 
) has a
typical nerve terminal pattern represented by small puncta
throughout the gray matter. Amphiphysin II (
 
A
 
, 
 
C
 
, and 
 
E
 
) is pri-
marily localized at initial axon segments. (
 
A
 
 and 
 
B
 
) cerebral cor-
tex. The inset of A shows high power views of two longitudinal
sections and one transverse section of initial axon segments. Note
the concentration of immunoreactivity in the cortical region of
the cytoplasm. (
 
C
 
 and 
 
D) CA1 region of the hippocampus dem-
onstrating in C the initial axon segments of pyramidal neurons
visible in D as negative images. (E and F) Cerebellar cortex. Ar-
rows point to the amphiphysin II positive initial segment of a
Purkinje cell axon, which is surrounded by amphiphysin I positive
nerve terminals of basket cells. Arrowheads in E point to initial
axon segments of stellate cells. Bar, 63 mm; inset, 126 mm.Butler et al. Amphiphysin II in Brain and Muscle 1361
from neuronal perikarya (Fig. 5, A, C, and E). In each re-
gion, the site of emergence of these processes and their
shape is consistent with their identification as axon initial
segments (Peters et al., 1991). High magnification views
indicate that amphiphysin II is strictly confined to the cor-
tical cytoplasm (Fig. 5 A, insets).
The specific localization of amphiphysin II at axon ini-
tial segments is further demonstrated in the high power
views of cerebellar sections double stained for amphi-
physin II and other protein markers (Fig. 6). Labeling for
MAP2, a marker of perikarya and dendrites (De Camilli
et al., 1984), demonstrates the origin of the amphiphysin II
positive process from a small indentation at the basal pole
of the cell (Fig. 6, A and B). Staining for glutamic acid de-
carboxylase, a marker of basket cell nerve terminals (Mug-
naini and Oertel, 1985), shows that the amphiphysin II-
positive region of the axon coincides with its unmyelinated
portion innervated by basket cells (Fig. 6, C and D). La-
beling for myelin basic protein illustrates the sharp bound-
ary between the amphiphysin II-positive portion of the
axon and its myelinated portion (Fig. 6, E and F).
In addition to axon initial segments, amphiphysin II im-
munoreactivity was also observed in spots sparsely distrib-
uted in the gray matter (which contains axons as well as
neuronal perikarya and dendrites) and more densely
packed in the white matter (which contains axon tracts
only). These spots are illustrated in Fig. 7, A and B, which
show brain regions double stained for amphiphysin II and
myelin basic protein. At high power, these immunoreac-
tive structures appear as bright rings overlapping with
axonal profiles (Fig. 7 C), very similar to the rings of am-
phiphysin II immunoreactivity visible at axon initial seg-
ments. The distribution of these structures and their fine
morphology allows their identification as nodes of Ranvier
(Peters et al., 1991).
The presence of amphiphysin II in the cortical region of
both axon initial segments and nodes of Ranvier is consis-
hypothesis was supported by the transfection of COS-7
cells with clones 17/12 and 17/19. Amphiphysin II immu-
noreactivity induced by these transfections comigrated
with amphiphysin IIa and IIb, respectively (Fig. 4). The
difference of z25 kD between amphiphysin IIa and IIb is
more than the difference expected by the inclusion of 127
amino acids. However, it was previously shown that amphi-
physin I has an aberrant mobility in SDS-PAGE, migrat-
ing significantly slower (z128 kD) than predicted by its
amino acid sequence (76 kD; Lichte et al., 1992; David et
al., 1994). This aberrant mobility is primarily due to a re-
gion (David et al., 1994) that strikingly corresponds to the
alternatively spliced region III in amphiphysin II.
To determine whether the SH3 domains of amphiphysin
I and II have similar properties, we carried out parallel
affinity-purification experiments of brain extracts on GST
fusion proteins comprising either one of the two SH3 do-
mains. Both amphiphysin SH3 domains were equally ef-
fective in binding dynamin I, but the SH3 domain of amphi-
physin II bound synaptojanin less effectively (not shown).
Thus, amphiphysin I and amphiphysin II’s SH3 domains
have similar but not identical binding properties.
Localization of Amphiphysin II in the Nervous System
Considering their significant primary sequence similarity,
amphiphysin I and II may have overlapping functions in
brain. Therefore, we investigated whether these two pro-
teins have a similar subcellular distribution by double im-
munofluorescence of rat brain frozen sections. Fig. 5
shows a comparison of the localization of amphiphysin I
and II in three different gray matter regions of the brain:
the cerebral cortex, the hippocampus, and the cerebellum.
In all regions, amphiphysin I immunoreactivity (Fig. 5, B,
D, and F) has the punctate distribution typical of nerve
terminal staining. In contrast, amphiphysin II immunore-
activity occurs in the shape of short segments emerging
Figure 6. Double immunofluorescence micrographs demonstrating the selective localization of amphiphysin II at axon initial segments.
(A and B) Amphiphysin II-MAP2 immunostaining demonstrating the emergence of the amphiphysin II positive segment from the
Purkinje cell body. (C and D) Amphiphysin II-GAD immunostaining demonstrating that the immunoreactive region of the axon corre-
sponds to its region enclosed by the GABAnergic nerve terminals (arrows) of basket cells. (E and F) Amphiphysin II-myelin basic pro-
tein immunostaining demonstrating that amphiphysin II immunostaining terminates abruptly (arrowhead) at the site where the myelin
sheath begins. Bar, 126 mm.The Journal of Cell Biology, Volume 137, 1997 1362
tent with the functional and structural similarity of these
two axonal portions (Waxman and Quick, 1978). An iden-
tical localization at both sites was previously reported for a
neuron-specific isoform of ankyrin3 (ankryinG; Kapfhamer
et al., 1995; Kordeli et al., 1995).
Localization of Amphiphysin II in Skeletal Muscle
The light microscopic localization of amphiphysin II in
skeletal muscle is illustrated in Fig. 8. Amphiphysin II im-
munoreactivity appears as transverse striations along the
muscle fiber (Fig. 8 A). These striations are within the I
band, as shown by counterstaining of actin by fluorescent
phalloidin (Fig. 8, B and C), and they flank the Z line, as
shown by counterstaining for desmin (Fig. 8, D and E).
The amphiphysin II stripes are similar to the stripes of
ankyrin3 (ankyrinG) immunoreactivity (Fig. 8, F and G, as
shown by double staining of ankyrin3 and actin). Ankyrin3
was previously shown to be concentrated along plasmalem-
mal T tubules (Flucher et al., 1990). Accordingly, the lo-
calization of amphiphysin II was also very similar to that
of triadin, a marker of T tubules (Guo et al., 1994; data not
shown). Immunoreactivity for clathrin heavy chain (mono-
clonal antibody X22), which was previously shown to be
concentrated in muscle at I bands (Muñoz et al., 1995a,b),
formed stripes comprised between the amphiphysin II stri-
ations and the Z line, as shown by double staining of am-
phiphysin II and clathrin (Fig. 8, H and I). The glucose
transporter, glut4, a protein that is internalized at least
partially via clathrin coated vesicles (Garippa et al., 1996;
Robinson et al., 1996), is also localized in proximity of T
tubules (Muñoz et al., 1995a). Glut4 immunoreactivity is
centered around the M line, as shown by double labeling
with anti-glut4 and anti-clathrin antibodies (Fig. 8, J and K).
The localization of amphiphysin II was further investi-
gated by immunogold labeling of ultrathin frozen sections
and found to be localized in correspondence with T tu-
bules (Fig. 9, B and D). The specificity of this labeling was
confirmed by labeling similar sections for desmin. As ex-
pected, desmin immunoreactivity was concentrated along
the Z line and absent from the T system (Fig. 9, A and C).
Cytoplasmic Localization of Amphiphysin II in 
Transfected Cells
Neither in brain nor in muscle (Figs. 5–8) was amphiphysin
II found to have a nuclear localization. This was in con-
trast to the nuclear localization of this protein (BIN1) re-
ported by Sakamuro et al. (1996) in transfected HepG2
cells. We examined, therefore, the localization of amphi-
physin IIa and IIb in transfected COS-7 cells as well as in
HepG2 cells transfected with the same clone (17/12, and
under the same experimental conditions) used by Saka-
muro et al. (1996). In all cases the protein was primarily lo-
calized in the cytosol (Fig. 10 and data not shown).
Discussion
We report here the characterization of an amphiphysin
gene (amphiphysin II) that is primarily, but not exclu-
sively, expressed in brain and skeletal muscle. The gene
undergoes extensive alternative splicing. Amphiphysin II
is substantially similar in amino acid sequence and domain
structure to amphiphysin I. The strongest similarity is
present in the A domain, which is predicted to form coiled
coil structures (Sivadon et al., 1995), and in the D domain,
which contains the SH3 domain (David et al., 1994). Do-
main A is characteristic of all proteins of the amphiphysin/
Rvs family identified so far, including the yeast protein
Rvs161, which is composed of the A domain only (David
et al., 1994; Sivadon et al., 1995). Due to these similarities,
the two amphiphysins are likely to have homologous func-
tions. However, their different cellular and subcellular lo-
calizations clearly indicate that their functions are not
overlapping.
In brain, amphiphysin I is concentrated in the cortical
cytoplasm of nerve terminals where it participates in syn-
aptic vesicle endocytosis (David et al., 1996; Shupliakov et al.,
1997). In contrast, amphiphysin II is concentrated in axon
initial segments and nodes of Ranvier. The occurrence of
clathrin coated pits and clathrin coated invaginations has
been reported to occur more frequently at initial segments
and nodes of Ranvier than at other locations along the ax-
Figure 7. Localization of amphiphysin II at nodes of Ranvier. (A
and B) Double immunofluorescence for amphiphysin II and mye-
lin basic protein. Field shown is from the forebrain including two
longitudinally sectioned white matter tracts. (A) Amphiphysin II
positive axon initial segments are visible in the gray matter (GM).
Small spots of amphiphysin II immunoreactivity visible on white
matter tracts (WM) represent nodes of Ranvier. (C) White mat-
ter region in the brain stem demonstrating front (double arrows)
and side (single arrows) views of nodes of Ranvier. The inset
shows at high power a bundle of cross-sectioned axons demon-
strating the localization of amphiphysin II in the cortical cyto-
plasm of nodes of Ranvier. Bar: (A and B) 27 mm; inset, 135 mm.Butler et al. Amphiphysin II in Brain and Muscle 1363
onal surface, with the exception of nerve terminals (Karls-
son, 1967; Campos-Ortega et al., 1968; Conradi, 1969). Thus,
an involvement of amphiphysin II in endocytosis is plausi-
ble. However, it is unlikely that the high and specific con-
centration of amphiphysin II present at these sites may be
simply related to endocytosis.
A characteristic feature of the cortical cytoplasm at ini-
tial segments and nodes of Ranvier is the presence of a
dense matrix underlying the plasmalemma (Palay et al.,
1968; Conradi, 1969; Waxman and Quick, 1978). This sub-
membranous cytoskeleton may participate in mediating
the local enrichment of special adhesion molecules (mem-
bers of the neurofascin/L1 family; Shiga and Oppenheim,
1991) and of proteins required for the generation and
propagation of action potentials, such as Na1 channels (Srin-
ivasan et al., 1988; Waxman and Ritchie, 1993), Na1/K1 ATP-
ase (Nelson and Veshnock, 1987; Waxman and Ritchie,
1993), and Na1/Ca21 exchangers (Waxman and Ritchie, 1993).
The only unique component of this specialized cortical cy-
tomatrix identified so far is a neuron-specific isoform of
ankyrin3 (ankyrinG; Kordeli et al., 1995). Neuronal amphi-
physin II may be a second component of this matrix. As in the
case of amphiphysin II, the isoform of ankyrin expressed
at axon initial segments and nodes of Ranvier is generated
by alternative splicing of a gene (ankyrin3) that is widely
expressed outside the nervous system, and at particularly
high concentrations in skeletal muscle (Kordeli et al., 1995).
In skeletal muscle, amphiphysin II is concentrated
around the plasmalemma of T tubules, and even here, it
colocalizes with ankyrin3, previously shown to be a com-
ponent of the submembranous cytoskeleton of T tubules
(Flucher et al., 1990). Like axon initial segments and
nodes of Ranvier, T tubules are enriched in proteins re-
sponsible for controlling ion permeability and transport
(Lau et al., 1979; Flucher et al., 1990) and a specialized cy-
tomatrix around the T tubules, including both amphiphysin
II and ankyrin3, may help to define the composition and
function of these plasmalemmal domains (Flucher et al.,
1990). T tubules are not typically regarded as sites special-
ized for endocytosis. However, there is evidence that
Figure 8. Immunofluores-
cence localization of amphi-
physin II and other proteins
of the sarcomere in skeletal
muscle. Immunofluorescence
of semithin frozen sections.
Amphiphysin II immunore-
activity (A, B, D, and H)
forms transverse bands that
flank the Z line. B–K show
pairs of double-fluorescence
micrographs. (B and C) Am-
phiphysin II and actin (phal-
loidin staining); (D and E)
amphiphysin II and desmin, a
marker of the Z line; (F and
G) ankyrin (ankyrin3) and
actin; (H and I) amphiphysin
II and clathrin heavy chain
(antibody X22); (J and K)
glut4 and clathrin. Arrows
equal Z and M lines, as indi-
cated. Bar, 7.9 mm.The Journal of Cell Biology, Volume 137, 1997 1364
Figure 9. Comparison of the localizations of desmin and amphiphysin II in skeletal muscle by electron microscopy immunocytochemis-
try. Ultrathin frozen sections were labeled by immunogold for desmin (A and C) and amphiphysin II (B, D and E). Desmin immunore-
activity is localized on a network of filamentous structures that are in register with Z lines. Amphiphysin is selectively localized at the T
system and is present on T tubules (E). Z, Z lines; T, T tubules; PM, plasmalemma. Bar: (A, B, and E) 300 nm; (C and D) 378 nm.Butler et al. Amphiphysin II in Brain and Muscle 1365
clathrin-mediated endocytosis may occur at this region.
First, clathrin immunoreactivity (detected by monoclonal
antibody X22) is present in proximity of T tubules as pre-
viously reported (Kaufman et al., 1990) and further con-
firmed by this study. This clathrin heavy chain is likely to
correspond to the skeletal muscle specific clathrin recently
described by several groups (Gong et al., 1996; Kedra et
al., 1996; Lindsay et al., 1996; Sirotkin et al., 1996). Second,
the glut4 transporter, which undergoes regulated surface
exposure in response to insulin (Wang et al., 1996) and is
internalized at least in part via clathrin coated vesicles
(Garippa et al., 1996; Robinson et al., 1996), is concen-
trated along the T system and surrounding vesicles (Slot
et al., 1991; Muñoz et al., 1995a,b).
In yeast, mutations in either the Rvs161 and/or the
RVS167 genes produce both endocytosis defects and de-
fects in the function of the peripheral actin cytoskeleton,
including abnormal polarity, uneven cell size and mor-
phology, and delocalization of actin patches (Munn et al.,
1995; Sivadon et al., 1995). The COOH-terminal region of
Rvs167 was identified in a two hybrid screen for actin
binding proteins (Amberg et al., 1995). More generally,
yeast studies have demonstrated an important role of the
actin cytoskeleton in endocytosis, thus raising the possibil-
ity that effects of RVS mutations on endocytosis and the
peripheral cytoskeleton may be interrelated (Munn and
Riezman, 1994; Amberg et al., 1995; Munn et al., 1995).
Our present demonstration that amphiphysin II is local-
ized in the cortical cytomatrix of specialized regions of ax-
ons and muscle is consistent with the role of the RVS
genes in actin function. A dual role in endocytosis and in
the dynamics of the peripheral cytoskeleton may be a gen-
eral characteristic of amphiphysin/Rvs family proteins.
The strong implication of amphiphysin I in synaptic vesicle
endocytosis may reflect the unique specialization of the
presynaptic actin cytomatrix for this function.
An additional phenotype produced by mutations in the
RVS genes is reduced viability upon starvation, a pheno-
type displayed by an inability of the cell to enter in station-
ary phase under these conditions (Crouzet et al., 1991;
Bauer et al., 1993). Since amphiphysin I was shown to be
an autoantigen in breast cancer (De Camilli et al., 1993;
David et al., 1994, 1996), it was speculated (David et al.,
1994) that proteins of the amphiphysin/Rvs family, like
other proteins of the cortical cell cytomatrix that can act as
tumor suppressors (Rubinfeld et al., 1993; Tsukita et al.,
1993), may be directly implicated in cancer.
While this study was in progress, sequences of amphi-
physin II isoforms were independently published in the
context of two studies. A first study reported the identifi-
cation of mouse muscle amphiphysin II during a search
for novel SH3-containing proteins (Sparks et al., 1996).
This protein (SH3P9) was not further characterized. A
second study identified a fragment of murine amphiphysin
II in a yeast two hybrid screen for MYC binding proteins
(Sakamuro et al., 1996). The authors of this study went on
to isolate a human amphiphysin II isoform, BIN1, which is
identical to our clone 17/12, and to demonstrate that this
protein is localized in the nucleus and has the properties of
a tumor suppressor gene. These findings are consistent
with the presence of a nuclear localization sequence in
BIN1 (Sakamuro et al., 1996), which we show here to be
encoded by splice fragment II (Fig. 1 B). In our study,
however, we do not have any evidence for a nuclear local-
ization of amphiphysin II in adult muscle or brain. Our re-
sults, therefore, argue for a primary function of amphi-
physin II in the cytoplasm, although they clearly do not
exclude that amphiphysin II may shuttle from the cyto-
plasm to the nucleus and that it may function in a signaling
pathway from the cell periphery to the nucleus. It was
shown previously that proteins of the submembranous cy-
toskeleton (e.g., the tight junction protein ZO1 [Gottardi
et al., 1996]) have a nuclear localization under certain con-
ditions. Thus, the possibility that amphiphysin II may par-
ticipate in nuclear events and even be concentrated in the
nucleus under certain functional states cannot be ruled out.
In conclusion, we suggest that amphiphysin/Rvs proteins
may play a general role in the physiology of the peripheral
cytoskeleton which underlies the plasmalemma. Different
isoforms, generated either by distinct genes or by alterna-
tive splicing of the same genes, may serve to adapt this
general role to specific functions of specialized cell surface
domains. Given the central importance of the subplas-
malemmal cytomatrix in a variety of cellular processes, in-
cluding vesicular trafficking to and from the plasmalemma,
generation of regional heterogeneity of plasmalemma, sig-
nal transduction, and regulation of cell–cell interaction,
the components of this matrix are likely to have pleiotro-
pic functions. Further studies of amphiphysin family mem-
bers may not only reveal new aspects of the function of the
peripheral cytoskeleton and endocytosis, but also help elu-
cidate a novel signaling pathway from the cell surface to
the nucleus. The reported connection between amphi-
physin I autoimmunity and cancer (Folli et al., 1993; De
Figure 10. Immunofluores-
cence localization of amphi-
physin II in transfected cells.
(A) COS-7 cells transfected
with clone 17-12 and exam-
ined by conventional epifluo-
rescence light microscopy. (B
and  C) HepG2 cells trans-
fected with clone 17/12 and
examined by confocal mi-
croscopy. The slight fluores-
cence visible in A over the
nuclei is out of the nuclei fo-
cal plane. Bar, (A) 12.6 mm;
(B and C) 9.0 mm.The Journal of Cell Biology, Volume 137, 1997 1366
Camilli et al., 1993) suggests that these studies may be of
relevance to the biology of at least some forms of human
cancer.
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